How Clinical Trial Imaging Can Impact Drug Clinical Development?

Drug development is struggling to successfully advance the most promising drug candidates through the clinical trial phase. Clinical Trial Imaging plays very important role in the world due to higher R&D expenditure, rising number of CROs, and increasing number of pharmaceutical and biotechnology companies. Moreover, it is anticipated to grow at the fastest rate in the globe owing to the growing industrialization, urbanization, and high per capita income.

Get Sample PDF Copy of this Study

The imaging systems are used in the non-clinical and clinical trials since ages for the detection of diseases. The clinical imaging is majorly used to obtain human physiology or anatomy information's which are undeniable and interpretable. The clinical inferences of an image are important in the evaluation of the drug effect. Clinical imaging is used on daily basis to detect, prevent, treat and manage various diseases or medical conditions.

Rising number of contract research organization, increase in geriatric population with chronic diseases, growth in R&D investments is expected to drive the growth of the market. Moreover, emerging of pharmaceutical and biotechnology industries and small and portable equipment are expected to provide opportunity for the growth of clinical trial imaging market during the forecast period.

In addition, the report focuses on leading industry players with information such as company profiles, products and services offered, financial information of last 3 years, key development in past five years.

1. Bioclinica

2. PAREXEL International Corporation

3. ICON plc

4. IXICO plc

5. Intrinsic Imaging, LLC

6. ERT Clinical

7. BioTelemetry, Inc.

8. Cardiovascular Imaging Technologies

9. Medical Metrics

10. Prism Clinical Imaging